Loading
KCN: what insiders have been doing
Every trade that managers of KCN disclose to ASX is tracked on this page. The company sits in the Chemicals sector. Over the twelve months to 18 October 2026, 7 filings were filed, from 4 insiders.
Only sales appear on the open market, 1 sale in all totalling €195k, filed by 1 insider. One trade stands out by size: a sale of €195k from Peter William Warren, disclosed on 4 May 2026, or 0.025% of market capitalisation.
The median gap between a trade and its publication by ASX is 2 days. This delay matters because a trade only becomes useful information once it is public. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
Compared with its exchange (2,527 companies, median 3 filings), a count of 7 filings is above the norm. Our records for KCN go back to 2026, with no purchases and 1 sale on the open market in total.
In the same sector, recent insider purchases at Culp Inc also feature in our signals. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
Insider Decl.
7
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€195,396
1 ops. · all time
Who traded when
BuySalePeter William Warren1 sale
Analyst consensus: bullish or bearish?
Analysts rate KCN Strong Buy (bullish), based on 3 analysts. Average price target: A$7.52.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 4,708 of 24,158 companies
67.1
score / 100
Value71
Quality64
FCF yld-0.6%
Earn yld15%
EV/EBITDA6.4x
ROE63%
Gross mgn7.8%
Net mgn·
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2024FY ended June 2024 · cache
A$4.99
Analyst consensus
3 analystsStrong buy
A$6.45Target A$7.52(+51%)A$8.10
Income statement
RevenueA$133.1M
Gross profitA$10.4M8% margin
EBITDAA$217.8M164% margin
Net incomeA$199.8M46.6% margin
Valuation
PER (trailing)4.7x
PER (forward)4.9x
P/Book2.4x
Beta1.35
Balance sheet & cash
Market capA$1.3B
Total debtA$59.4M
Free Cash Flow-A$7.7M
Debt / Equity12%
Profitability & ownership
ROE63.3%
ROA26.5%
% insiders9.6%
% institutions36.8%
Last declaration on 2 October 2026
Declarations7 total
ShareASXASX:2924-03143967-2A1701604
ShareASXASX:2924-03141835-2A1700445
ShareASXASX:2924-03107567-2A1682201
ShareASXASX:2924-03106525-2A1681337
ShareASXASX:2924-03097870-2A1676184
ShareASXASX:2924-03087601-2A1670788
50,000 shares@ A$6.36570.025% mcap100.0% of flowShareASXASX:2924-03086237-2A1669839
7 of 7 declarations
About KCN
KCN is a company operating in the chemicals and materials sector. It is listed on the XASX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
